Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
IPA launches a digital campaign to ensure uninterrupted medicines supply during COVID-19 pandemic
The campaign, called Mission Medicine- Delivering Life, aims to bring to light the human stories of the contributions made by…
DKSH to commercialise seven generic formulations of Biocon Pharma in Singapore and Thailand
The formulations belong to various therapeutic areas like diabetology, cardiology, oncology and immunology
Chinese researchers launch phase-2 human test for possible coronavirus vaccine
IMBCAMS began a phase 2 human test for its experimental shot, which is among six possible vaccines Chinese scientists are testing…
Cipla launches remdesivir under brand name CIPREMI
The product will be in the form of lyophilised powder for injection 100 mg
Maha govt plans to procure 10000 vials of remdesivir from Cipla
It also plans to procure favipiravir from Glenmark
Hetero announces launch of generic remdesivir ‘COVIFOR’ for COVID-19 treatment
COVIFOR will be available in 100 mg vial (injectable) which has to be administered intravenously in a hospital setting under the…
Unichem, Lupin voluntarily recall hypertension medicines in the US
Unichem is recalling 1,90,992 bottles of Clonodine Hydrochloride tablets while Lupin is recalling 4,224 bottles of Lisinopril…
Cipla, Hetero get DCGI nod to manufacture remdesivir
With this move, domestic production of remdesivir for “restricted emergency use” can begin
India: A global nutraceutical hub in the making
Amit Srivastava, Nutrition Evangelist at Nutrify India showcases the huge opportunity that nutraceuticals present for growth and…
US FDA declines approval again for Nabriva’s antibiotic for UTI
The company said it plans to request a meeting with the FDA to discuss the next steps